These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16407246)

  • 21. Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain.
    Abe T; Matsumura S; Katano T; Mabuchi T; Takagi K; Xu L; Yamamoto A; Hattori K; Yagi T; Watanabe M; Nakazawa T; Yamamoto T; Mishina M; Nakai Y; Ito S
    Eur J Neurosci; 2005 Sep; 22(6):1445-54. PubMed ID: 16190898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J; Ohdo S; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptors are involved in the regulation of Fyn and metabotropic glutamate receptor 5 phosphorylation in the rat striatum in vivo.
    Mao LM; Wang JQ
    J Neurosci Res; 2016 Apr; 94(4):329-38. PubMed ID: 26777117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
    Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of Haloperidol-Induced Catalepsy by GPR143, an L-Dopa Receptor, in Striatal Cholinergic Interneurons.
    Arai M; Suzuki E; Kitamura S; Otaki M; Kanai K; Yamasaki M; Watanabe M; Kambe Y; Murata K; Takada Y; Arisawa T; Kobayashi K; Tajika R; Miyazaki T; Yamaguchi M; Lazarus M; Hayashi Y; Itohara S; de Kerchove d'Exaerde A; Nawa H; Kim R; Bito H; Momiyama T; Masukawa D; Goshima Y
    J Neurosci; 2024 Mar; 44(11):. PubMed ID: 38286627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor.
    Nakazawa T; Komai S; Tezuka T; Hisatsune C; Umemori H; Semba K; Mishina M; Manabe T; Yamamoto T
    J Biol Chem; 2001 Jan; 276(1):693-9. PubMed ID: 11024032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
    Moore NA; Blackman A; Awere S; Leander JD
    Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Gomez G; Saborido MD; Bernardi MA; Gershanik OS; Taravini IR; Ferrario JE
    Neurosci Lett; 2018 Feb; 666():5-10. PubMed ID: 29241709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.
    Sanz-Blasco S; Bordone MP; Damianich A; Gomez G; Bernardi MA; Isaja L; Taravini IR; Hanger DP; Avale ME; Gershanik OS; Ferrario JE
    Mol Neurobiol; 2018 Jun; 55(6):5125-5136. PubMed ID: 28840468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice.
    Adams MR; Brandon EP; Chartoff EH; Idzerda RL; Dorsa DM; McKnight GS
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12157-61. PubMed ID: 9342379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
    Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
    J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain.
    Suzuki T; Okumura-Noji K
    Biochem Biophys Res Commun; 1995 Nov; 216(2):582-8. PubMed ID: 7488151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.
    Hu JL; Liu G; Li YC; Gao WJ; Huang YQ
    Mol Brain; 2010 Jun; 3():20. PubMed ID: 20569495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
    Klemm WR
    Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy.
    Crocker AD; Hemsley KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):573-90. PubMed ID: 11370998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.